Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Datadog Inc (DDOG) vs Medpace Holdings Inc (MEDP) Price & Performance

Datadog IncTrade
Medpace Holdings IncTrade

Price performance (Past 24H)

Key statistics

Datadog Inc vs Medpace Holdings Inc — how do they compare? Datadog Inc trades at $240.89 (market cap $88.61B), while Medpace Holdings Inc trades at $600 (market cap $16.90B). The key difference: Datadog Inc is far larger — about 5.2× Medpace Holdings Inc's market cap, and Medpace Holdings Inc is trading nearer its 52-week high, Datadog Inc nearer its low. Which is the better fit depends on your goals.

DDOGMEDP
Market Cap
$88.61B$16.90B
Sector
TechnologyTechnology
52-Week High
$288.15$620.59
52-Week Low
$102.62$393.42
Enterprise Value
$84.90B$16.52B

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

Datadog Inc

Datadog (DDOG) trades at $244.2, down 6.36% over 24 hours, with a bearish technical signal despite strong Q2 2026 earnings beats and raised full-year guidance. Revenue grew 36% year-over-year to $1.12 billion, but the stock faces pressure from high valuations (P/E 493.56) and concerns over a major customer's reduced usage. Analyst consensus remains strongly bullish with an 83.34% buy rating and a $288.55 price target, suggesting significant upside potential from current levels.

The outlook is mixed: robust fundamentals and AI-driven growth support long-term value, but near-term volatility persists due to premium valuation and investor skepticism post-earnings. Key risks include customer concentration, competitive pressures, and execution challenges in sustaining high growth rates. Investors should weigh strong analyst conviction against technical weakness and market sentiment shifts.

Medpace Holdings Inc

MEDP trades at $600.32, down 0.35% on the day, with a bullish technical signal supported by moving averages. The stock shows strong fundamentals with Q2 2026 earnings beating estimates at $4.25 per share versus $3.98 expected, and revenue growth projected from $2.53B in 2025 to $2.8B in 2026. Recent news highlights record bookings and raised guidance, though valuation ratios remain elevated with a P/E of 35.58 and P/B of 38.95.

Outlook remains positive driven by earnings momentum and strong backlog visibility, but risks include premium valuation compression and ongoing legal scrutiny. Analyst consensus is cautious with 73.7% hold ratings, though institutional interest persists with California State Teachers Retirement System increasing its position by 22.1% in Q1 2026.

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

About Datadog Inc

Datadog is a cloud-native company that focuses on analyzing machine data. The firm's product portfolio, delivered as software-as-a-service, allows a client to monitor and analyze its entire IT infrastructure. Datadog's platform can ingest and analyze large amounts of machine-generated data in real time, allowing clients to utilize it for a variety of different applications throughout their businesses.

Read more on DDOG

About Medpace Holdings Inc

Medpace Holdings, Inc. is a full-service clinical contract research organization (CRO) that provides comprehensive and scientifically-driven clinical development services to the biotechnology, pharmaceutical, and medical device industries. The company specializes in conducting global clinical trials for new drug and medical device approvals. Medpace's model emphasizes therapeutic expertise and a highly integrated approach to accelerate the clinical development process for its clients.

Read more on MEDP